12.02Open8.70Pre Close1 Volume1 Open Interest82.00Strike Price1.20KTurnover6787.50%IV0.53%PremiumNov 1, 2024Expiry Date11.65Intrinsic Value100Multiplier0DDays to Expiry0.37Extrinsic Value100Contract SizeAmericanOptions Type-0.9325Delta0.0186Gamma5.94Leverage Ratio-559.5480Theta0.0000Rho-5.54Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet